GLP-1 (glucagon-like peptide-1) is released from L-cells in the small and large intestine
Overall, the ES paradigms affected behavior in 82.00% of the cases, this was consistent across the behavioral domains assessed (depressive-like behavior 82.35%, anxiety-like behavior 78.57%, cognitive deficits 85.00% and social deficits 80.00% and other ES-induced behaviors 90.00%)
References 1 OgdenCLCarrollMDCurtinLRMcDowellMATabakCJFlegalKM
In addition, this parameter was recorded for the study of lipid profile, considering the demonstrated role of oxidative stress, both in the induction of cardiac arrhythmias and in lipid oxidation with subsequent development of an immune response, with a pathogenic evolution towards accelerated atherosclerotic endothelial dysfunction (4)
When you choose Semaglutide, youre not just receiving a medicationyoure becoming part of a supportive community dedicated to your well-being
It's important to note that while Ozempic is licensed specifically for type 2 diabetes, Wegovy is the brand name for semaglutide that is licensed for weight management in the UK
